PROF (STOCKS)
Profound Medical Corp. Common Stock
$6.270000
+0.320000 (+5.38%)
Prev close: $5.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Arun S. Menawat
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $227.56M
- Employees
- 142
- P/E (TTM)
- -4.22
- P/B (TTM)
- 3.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.27 | $-0.27 | -0.0007 | -0.26% |
|
Sep 2025 (Q3)
|
$-0.26 | $-0.37 | +0.1087 | +29.48% |
|
Jun 2025 (Q2)
|
$-0.52 | $-0.37 | -0.1488 | -40.09% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.28 | -0.0772 | -27.30% |
Financial Statements
| Revenues | $16.10M |
| Benefits Costs and Expenses | $58.42M |
| Cost Of Revenue | $4.71M |
| Costs And Expenses | $58.42M |
| Gross Profit | $11.39M |
| Nonoperating Income/Loss | -$1.06M |
| Operating Expenses | $52.65M |
| Selling, General, and Administrative Expenses | $32.05M |
| Research and Development | $20.60M |
| Operating Income/Loss | -$41.25M |
| Income/Loss From Continuing Operations After Tax | -$42.57M |
| Income/Loss From Continuing Operations Before Tax | -$42.32M |
| Income Tax Expense/Benefit | $252.00K |
| Income Tax Expense/Benefit, Current | $231.00K |
| Income Tax Expense/Benefit, Deferred | $21.00K |
| Net Income/Loss | -$42.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$42.57M |
| Net Income/Loss Available To Common Stockholders, Basic | $42.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$85.14M |
| Preferred Stock Dividends And Other Adjustments | -$85.14M |
| Basic Earnings Per Share | $1.41 |
| Diluted Earnings Per Share | $1.41 |
| Basic Average Shares | 30,232,966 |
| Diluted Average Shares | 30,232,966 |
| Assets | $77.48M |
| Current Assets | $76.09M |
| Inventory | $8.24M |
| Other Current Assets | $67.85M |
| Noncurrent Assets | $1.39M |
| Fixed Assets | $698.00K |
| Other Non-current Assets | $688.00K |
| Liabilities | $11.04M |
| Current Liabilities | $6.08M |
| Accounts Payable | $1.56M |
| Wages | $2.35M |
| Other Current Liabilities | $2.17M |
| Noncurrent Liabilities | $4.97M |
| Long-term Debt | $4.50M |
| Other Non-current Liabilities | $467.00K |
| Equity | $66.43M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $66.43M |
| Liabilities And Equity | $77.48M |
| Net Cash Flow From Operating Activities | -$38.21M |
| Net Cash Flow From Operating Activities, Continuing | -$38.21M |
| Net Cash Flow From Investing Activities | -$242.00K |
| Net Cash Flow From Investing Activities, Continuing | -$242.00K |
| Net Cash Flow From Financing Activities | $41.14M |
| Net Cash Flow From Financing Activities, Continuing | $41.14M |
| Net Cash Flow | $2.69M |
| Net Cash Flow, Continuing | $2.69M |
| Comprehensive Income/Loss | -$40.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$40.29M |
| Other Comprehensive Income/Loss | $2.28M |